Who
Rutul R. Shah
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Precigen.
In numbers
- Trades disclosed
- 81
- Buys
- 2
- Sells
- 10
- Bought
- $23K
- Sold
- $2.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Jan 2023
- Last trade
- 25 Aug 2026
- Last filed
- 25 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,342 at $0.00 | filing |
| 25 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $36K15,342 at $2.33 | filing |
| 25 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Sold | $115K15,342 at $7.50 | filing |
| 25 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,342 at $0.00 | filing |
| 25 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $36K15,342 at $2.33 | filing |
| 25 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Sold | $115K15,342 at $7.50 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code F | $26K3,647 at $7.20 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code F | $26K3,647 at $7.20 | filing |
| 21 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $81K34,658 at $2.33 | filing |
| 21 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Sold | $260K34,658 at $7.50 | filing |
| 21 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —34,658 at $0.00 | filing |
| 21 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —34,658 at $0.00 | filing |
| 21 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $81K34,658 at $2.33 | filing |
| 21 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Sold | $260K34,658 at $7.50 | filing |
| 6 Aug 2026filed 7 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Sold | $225K32,739 at $6.86 | filing |
| 6 Aug 2026filed 7 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Sold | $225K32,739 at $6.86 | filing |
News
No headline names them, or the companies they trade most, lately.